학술논문
PCN8 OUTCOMES AND COSTS OF SURROGATE END-POINTS (SES) AND BIOMARKERS IN PHASE I ONCOLOGY CLINICAL TRIALS
Document Type
Abstract
Author
Source
In Value in Health 2004 7(3):248-248
Subject
Language
ISSN
1098-3015